Does anti-nerve growth factor monoclonal antibody treatment have the potential to replace nonsteroidal anti-inflammatory drugs and opioids in treating hip or knee osteoarthritis? A systematic review of randomized controlled trials

Zhao, D; Zeng, LF; Liang, GH; Pan, JK; Luo, MH; Han, YH; Liu, J; Yang, WY

Yang, WY (通讯作者)，Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangzhou, Peoples R China.;Liu, J (通讯作者)，Guangdong Prov Acad Chinese Med Sci, Bone & Joint Res Team Degenerat & Injury, Guangzhou, Peoples R China.;Liu, J (通讯作者)，Guangdong Second Tradit Chinese Med Hosp, Guangdong Prov Engn Technol Res Inst Tradit Chine, Guangzhou, Peoples R China.;Liu, J (通讯作者)，Guangzhou Univ Chinese Med, Clin Med Coll 5, Guangzhou, Peoples R China.

EFORT OPEN REVIEWS, 2022; 7 (7): 470

Abstract

center dot Purpose: Considering the adverse effects of nonsteroidal anti-inflammatory drugs (NSAIDs) and opioids for treating osteoarthritis (OA), dev......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索